We are live on ! Find out more
NGNE icon

Neurogene
NGNE

35 hedge funds and large institutions have $186M invested in Neurogene in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,187% more capital invested

Capital invested by funds: $14.4M → $186M (+$171M)

64.32% more ownership

Funds ownership: 10.36% → 74.68% (+64%)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

13% more funds holding

Funds holding: 31 → 35 (+4)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
9
Reduced
7
Closed
10
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$18.2M
2
SB
Samsara BioCapital
California
+$18.2M
3
GPP
Great Point Partners
Connecticut
+$14.2M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.1M
5
RG
Redmile Group
California
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$149K
2
Two Sigma Investments
Two Sigma Investments
New York
-$135K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$134K
4
Bank of America
Bank of America
North Carolina
-$118K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$24.6M +$18.2M +1,271,342 New
SB
2
Samsara BioCapital
California
$24.6M +$18.2M +1,267,790 New
GPP
3
Great Point Partners
Connecticut
$19.3M +$14.2M +994,229 New
RG
4
Redmile Group
California
$18.4M +$11.5M +801,286 +550%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$16.3M +$12.1M +841,688 New
CAM
6
Cormorant Asset Management
Massachusetts
$14.5M +$10.7M +746,180 New
Morgan Stanley
7
Morgan Stanley
New York
$13.2M +$9.35M +653,040 +2,426%
ACH
8
ArrowMark Colorado Holdings
Colorado
$10.2M +$7.53M +525,529 New
CC
9
Casdin Capital
New York
$10.2M +$7.51M +524,616 New
APM
10
Avidity Partners Management
Texas
$9.04M +$6.68M +466,243 New
BBA
11
Baker Bros. Advisors
New York
$8.79M +$2.12M +148,162 +49%
Walleye Capital
12
Walleye Capital
New York
$3.65M +$2.7M +188,501 New
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$2.63M +$832K +58,081 +75%
CH
14
CVI Holdings
Delaware
$2.46M +$1.73M +120,496 +1,934%
NCM
15
Nantahala Capital Management
Connecticut
$1.4M -$39K -2,721 -4%
ACM
16
Altium Capital Management
New York
$1.3M +$959K +66,981 New
Vanguard Group
17
Vanguard Group
Pennsylvania
$977K +$516 +36 +0.1%
Renaissance Technologies
18
Renaissance Technologies
New York
$973K +$134K +9,332 +23%
Bank of America
19
Bank of America
North Carolina
$964K -$118K -8,216 -14%
BCM
20
BML Capital Management
Indiana
$478K – – –
BlackRock
21
BlackRock
New York
$468K -$29 -2 -0%
ECM
22
ExodusPoint Capital Management
New York
$394K +$291K +20,306 New
Bessemer Group
23
Bessemer Group
New Jersey
$388K +$286K +20,000 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$305K -$29 -2 -0%
ACM
25
ADAR1 Capital Management
Texas
$105K +$77.4K +5,405 New
1
2

NGNE Hedge Fund Activity: Q4 2023 in Review

35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2023, worth a combined $186M — up 1,187% from $14.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NGNE positions and 10 closed out — a net gain of 4 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $18.2M. The largest seller was Millennium Management, exiting entirely with an estimated $149K sold.

  • 35 institutional investors held Neurogene (NGNE) as of Q4 2023, up from 31 in Q3 2023.
  • Funds reported $186M of Neurogene stock for Q4 2023, up 1,187% quarter-over-quarter.
  • 14 funds opened new Neurogene positions in Q4 2023 and 10 closed out, a net change of +4 holders.
  • The largest Neurogene buyer in Q4 2023 was EcoR1 Capital, an estimated $18.2M added.
  • The largest Neurogene seller in Q4 2023 was Millennium Management, an estimated $149K sold.

Based on aggregated 13F filings for Q4 2023.